# Effects of Glutamine on GLP-1 and Insulin Secretion in Man

> **NCT00673894** · NA · COMPLETED · sponsor: **Garvan Institute of Medical Research** · enrollment: 22 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00673894
- **Lead sponsor:** Garvan Institute of Medical Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-12
- **Final completion:** 2014-11
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673894, "Effects of Glutamine on GLP-1 and Insulin Secretion in Man". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00673894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*